Giacomin Jon L 4
4 · CARDINAL HEALTH INC · Filed Feb 20, 2018
Insider Transaction Report
Form 4
Giacomin Jon L
CEO, Pharmaceutical Segment
Transactions
- Award
Common Shares
2018-02-15+14,684→ 63,043 total - Sale
Common Shares
2018-02-20$68.65/sh−5,724$392,953→ 57,319 total - Sale
Common Shares
2018-02-20$69.12/sh−2,271$156,972→ 55,048 total
Footnotes (3)
- [F1]Grant of restricted share units that vest on February 15, 2019.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.01 to $69.00, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.03 to $69.20, inclusive.